praziquantel has been researched along with Granulomas in 95 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study evaluated the effect of oral administration of five days celecoxib regimen (20 mg/kg/day) against different developmental stages of Schistosoma mansoni infection." | 8.02 | Effect of celecoxib against different developmental stages of experimental Schistosoma mansoni infection. ( Abou-El-Naga, IF; El-Temsahy, MM; Ibrahim, EI; Makled, S; Mogahed, NMFH; Sheta, E, 2021) |
| "In view of the potential immunosuppressive and regenerative properties of mesenchymal stem cells (MSC), we investigated whether transplantation of adipose tissue-derived stem cells (ASC) could be used to control the granulomatous reaction in the liver of mice infected with Schistosoma mansoni after Praziquantel (PZQ) treatment." | 7.96 | Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment. ( Alves, ÉAR; Bicalho, KA; Birbrair, A; Bozzi, A; Chaves, AT; Corrêa-Oliveira, R; de Goes, AM; Eller, DE; Ferraz, LCN; Gomes, TR; Miranda, VHS; Pascoal Xavier, MA; Silva, CEC, 2020) |
| "A dual drug repurposing/nanotechnological approach was used to develop an alternative oral treatment for schistosomiasis mansoni using miltefosine (MFS), an anticancer alkylphosphocholine, and lipid nanocapsules (LNCs) as oral nanovectors." | 7.83 | Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni. ( Eissa, MM; El-Azzouni, MZ; El-Khordagui, LK; El-Moslemany, RM; Ramadan, AA, 2016) |
| "Taken together, these data suggest that the combined treatment of PZQ and edelfosine promotes a high decrease in granuloma formation, as well as in the cellular immune response that underlies granuloma development, with changes in the cytokine patterns, and may provide a promising and effective strategy for a prophylactic treatment of schistosomiasis." | 7.81 | Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel. ( López-Abán, J; Mollinedo, F; Muro, A; Rojas-Caraballo, J; Varela-M, RE; Yepes, E, 2015) |
| "We sought to determine whether praziquantel reverses established pulmonary vascular remodeling and pulmonary hypertension in a mouse model of S." | 7.77 | Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis. ( Butrous, G; Crosby, A; Dunne, DE; Jones, FM; Kolosionek, E; Morrell, NW; Purvis, I; Soon, E; Southwood, M, 2011) |
| "This study is a trial to demonstrate the effect of the broad spectrum anthelmintic drug flubendazole (methyl 5-(p-fluoro-benzoyl)-2-benzimidazolecarbamate, CAS 31430-15-6), a mebendazole derivative, together with praziquantel (CAS 55268-74-1, EMBAY 8440, Biltricide) in murine schistosomiasis mansoni." | 7.72 | Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection. ( Guirguis, F; Nessim, NG; William, S, 2003) |
| "The effect of treatment with praziquantel (PZQ) on the tegument of adult Schistosoma mansoni worms and on liver egg-granulomas has been examined in mice infected with PZQ-resistant and -susceptible parasite isolates." | 7.71 | Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo. ( Coles, GC; Dai, JR; Doenhoff, MJ; Liang, YS; Zhu, YC, 2002) |
| "This study was conducted to evaluate the efficacy of praziquantel (CAS 55268-74-1, EMBAY 8440, Biltricide) in different grades of Schistosoma mansoni infection." | 7.70 | Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni. ( Demerdash, Z; Nessim, NG, 2000) |
| "Colchicine treated mice showed significant decrease in prevalence of fibrocellular and fibrocellular and fibrous granulomas in liver specimens compared to corresponding control groups." | 7.69 | Histopathological evidences for the antifibrogenic effect of colchicine in schistosomiasis mansoni in mice. ( el-Monayerhy, MS; Fahmy, IA; Montasser, MF; Rashad, MS; Sabry, NM; Younis, TA, 1994) |
| "We describe the parameters useful in evaluating the development of hepatic fibrosis in Schistosoma japonicum infection, as well as its improvement after treatment with praziquantel (PZQ)." | 7.68 | Serologic and ultrasonographic parameters of praziquantel treatment of hepatic fibrosis in Schistosoma japonicum infection. ( Irie, Y; Nara, T; Ohmae, H; Taguchi, H; Tanaka, M; Utsunomiya, H; Yasuraoka, K, 1991) |
| " The effect of treatment with praziquantel at 8, 12, and 20 weeks postinfection on fibrosis was assessed by determination of total hepatic collagen content, ratio of type III/I + III collagen, granuloma volume, and histopathological examination of liver section." | 7.67 | Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni. ( Abdallah, NM; Botros, SS; el-Badrawy, NM; Hassanein, HI; Herbage, D; Nagy, FM, 1988) |
| "Curcumin-treated groups, with and without PZQ, resulted in higher significant Immunoreactivity score (IRS) for Bcl-2-associated X (BAX) and lower Interleukine- 17A (IL-17A), and Human epidermal growth factor (EGF), compared to the control." | 5.72 | Potentiality of curcumin on ISHAK scoring system and the expressions of BAX, IL-17A, and EGF in the treatment ofSchistosoma mansoni infection using Swiss albino mice. ( Abd-Elaal, AA; Amin, NM; El Saftawy, EA; El-Dardiry, MA; Negm, MSI, 2022) |
| "Schistosomiasis is still a major health problem affecting nearly 250 million people worldwide and causes approximately 280,000 deaths per year." | 5.72 | Anti-inflammatory, antioxidant, anti-fibrotic and schistosomicidal properties of plumbagin in murine schistosomiasis. ( Abdel-Latif, M; Abuelsaad, ASA; Allam, GA; Bakery, HH; Elkenawy, AE; Khalil, RG, 2022) |
| "Schistosomiasis mansoni is considered one of the most common fibrotic diseases resulting from inflammation and deposition of fibrous tissue around parasitic eggs trapped in the liver, causing morbidity and mortality." | 5.48 | Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection. ( El-Sayed, SH; Mahmoud, SS; Negm, MSI; Raafat, A; Rizk, EMA; Sobhy, MMK, 2018) |
| "Praziquantel (PZQ) has shown some anti-schistosomal effect, but little information is available about the effect of PZQ-prolonged administration on granuloma formation around schistosome eggs." | 5.42 | Transdermal praziquantel administration attenuates hepatic granulomatosis in mice infected with Schistosoma japonicum. ( Bao-an, Y; Jiang-shan, D; Li-zhi, W; Xin-Sheng, Z; Yi, W, 2015) |
| "Praziquantel is an effective antischistosomal drug especially for adult worms." | 5.37 | Effect of praziquantel prolonged administration on granuloma formation around Schistosoma japonicum eggs in lung of sensitized mice. ( Huang, YX; Li, HJ; Liang, YS; Wang, TS; Wang, W; Xu, YL; Yin, XR; Yu, CX, 2011) |
| "Pentoxifylline (PTX) was proved to exert both anti-inflammatory and anti-fibrotic effects, and was used therapeutically in this experimental model to investigate its role alone or with praziquantel (PZQ) in Schistosoma mansoni-infected mice, and to explore its impact on the tissue expression of transforming growth factor-beta1 (TGF-beta1)." | 5.34 | Pharmacodynamics of pentoxifylline and/or praziquantel in murine schistosomiasis mansoni. ( El-Lakkany, N; Nosseir, M, 2007) |
| " These effects were more pronounced with dosing regimens launched before the time of oviposition." | 5.32 | Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice. ( Botros, S; Hammam, O; Holý, A; William, S; Zídek, Z, 2003) |
| "In praziquantel-treated mice (500 mg/kg for 2 days orally), the reduction in the percent resistance (45." | 5.28 | Levamisole restored the compromised state of immunity after specific chemotherapy in experimental schistosomiasis mansoni. ( Azab, ME; Botros, SS; el-Garem, A; el-Nahal, HM; Hassan, SI; Shaker, ZA, 1989) |
| "Mice treated with praziquantel showed a prompt decrease in S." | 5.27 | Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. ( Dunn, MA; Girgis, NI; Ishak, EA; Khayyal, MT; Mansour, MM; Morcos, SH; Saleh, S, 1985) |
| "Anthelminthic treatment with albendazole provides improved rates of seizure freedom and hastens resolution of the granuloma." | 4.89 | Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis. ( Otte, WM; Sander, JW; Singh, G; Singla, M, 2013) |
| " The present study evaluated the effect of oral administration of five days celecoxib regimen (20 mg/kg/day) against different developmental stages of Schistosoma mansoni infection." | 4.02 | Effect of celecoxib against different developmental stages of experimental Schistosoma mansoni infection. ( Abou-El-Naga, IF; El-Temsahy, MM; Ibrahim, EI; Makled, S; Mogahed, NMFH; Sheta, E, 2021) |
| "In view of the potential immunosuppressive and regenerative properties of mesenchymal stem cells (MSC), we investigated whether transplantation of adipose tissue-derived stem cells (ASC) could be used to control the granulomatous reaction in the liver of mice infected with Schistosoma mansoni after Praziquantel (PZQ) treatment." | 3.96 | Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment. ( Alves, ÉAR; Bicalho, KA; Birbrair, A; Bozzi, A; Chaves, AT; Corrêa-Oliveira, R; de Goes, AM; Eller, DE; Ferraz, LCN; Gomes, TR; Miranda, VHS; Pascoal Xavier, MA; Silva, CEC, 2020) |
| " The effect of prolonged administration of bevacizumab with praziquantel was also assessed through parasitic load, protective index, granuloma and fibrous tissue evaluation." | 3.96 | Bevacizumab as a potential anti-angiogenic therapy in schistosomiasis: A double-edged, but adjustable weapon. ( El-Anwar, N; Hasby Saad, MA, 2020) |
| "A dual drug repurposing/nanotechnological approach was used to develop an alternative oral treatment for schistosomiasis mansoni using miltefosine (MFS), an anticancer alkylphosphocholine, and lipid nanocapsules (LNCs) as oral nanovectors." | 3.83 | Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni. ( Eissa, MM; El-Azzouni, MZ; El-Khordagui, LK; El-Moslemany, RM; Ramadan, AA, 2016) |
| "Taken together, these data suggest that the combined treatment of PZQ and edelfosine promotes a high decrease in granuloma formation, as well as in the cellular immune response that underlies granuloma development, with changes in the cytokine patterns, and may provide a promising and effective strategy for a prophylactic treatment of schistosomiasis." | 3.81 | Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel. ( López-Abán, J; Mollinedo, F; Muro, A; Rojas-Caraballo, J; Varela-M, RE; Yepes, E, 2015) |
| "This study aims to evaluate the immunomodulatory effects of a natural product, blue green algae (BGA) (100 mg/kg BW), alone or combined with praziquantel PZQ (250 mg/kg BW) on granulomatous inflammation, liver histopathology, some biochemical and immunological parameters in mice infected with Schistosoma mansoni." | 3.80 | The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice. ( Elmalawany, AM; Mohamed, AH; Osman, GY; Salem, TA, 2014) |
| " Treatment of infected mice with Pps, although failed to eradicate the worm, significantly reduced the hepatic granuloma number, their lymphocytic infiltration and aggregation, hepatic and splenic myeloperoxidase (MPO) activity and plasma, and liver and thymus nitric oxide (NOx) levels together with normalization of plasma proteins and alleviation of oxidative stress in the examined tissues as evidenced by reduction of malondialdehyde (MDA) and normalization of glutathione (GSH)." | 3.80 | Propolis enhances the effectiveness of praziquantel in experimental schistosomiasis: biochemical and histopathological study. ( Maghraby, AS; Mahmoud, TY; Rizk, SM; Shaheen, AA, 2014) |
| "The present study evaluated the use of 3 types of Cysteine Protease Inhibitors (CPIs) with praziquantel (PZQ) as chemotherapy against schistosomiasis mansoni in mice." | 3.79 | Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile. ( El Amir, AM; Farid, A; Helmy, A; Malek, AA; Rabie, I, 2013) |
| "We sought to determine whether praziquantel reverses established pulmonary vascular remodeling and pulmonary hypertension in a mouse model of S." | 3.77 | Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis. ( Butrous, G; Crosby, A; Dunne, DE; Jones, FM; Kolosionek, E; Morrell, NW; Purvis, I; Soon, E; Southwood, M, 2011) |
| "This study is a trial to demonstrate the effect of the broad spectrum anthelmintic drug flubendazole (methyl 5-(p-fluoro-benzoyl)-2-benzimidazolecarbamate, CAS 31430-15-6), a mebendazole derivative, together with praziquantel (CAS 55268-74-1, EMBAY 8440, Biltricide) in murine schistosomiasis mansoni." | 3.72 | Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection. ( Guirguis, F; Nessim, NG; William, S, 2003) |
| "The effect of treatment with praziquantel (PZQ) on the tegument of adult Schistosoma mansoni worms and on liver egg-granulomas has been examined in mice infected with PZQ-resistant and -susceptible parasite isolates." | 3.71 | Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo. ( Coles, GC; Dai, JR; Doenhoff, MJ; Liang, YS; Zhu, YC, 2002) |
| "This study was conducted to evaluate the efficacy of praziquantel (CAS 55268-74-1, EMBAY 8440, Biltricide) in different grades of Schistosoma mansoni infection." | 3.70 | Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni. ( Demerdash, Z; Nessim, NG, 2000) |
| "Colchicine treated mice showed significant decrease in prevalence of fibrocellular and fibrocellular and fibrous granulomas in liver specimens compared to corresponding control groups." | 3.69 | Histopathological evidences for the antifibrogenic effect of colchicine in schistosomiasis mansoni in mice. ( el-Monayerhy, MS; Fahmy, IA; Montasser, MF; Rashad, MS; Sabry, NM; Younis, TA, 1994) |
| "In infected mice, pyridinoline increased mainly in the isolated granulomas, corresponding to the fibrotic lesions, and slightly in the surrounding parenchyma." | 3.69 | Urinary excretion of the collagen cross-link pyridinoline increases during liver fibrogenesis. ( Blanquier, B; Grenard, P; Ricard-Blum, S, 1997) |
| "Non steroidal anti-inflammatory drugs (NSAIDs) (tiaprofenic acid and piroxicam have been used alone and as adjuvants to praziquantel in treating hepatic granuloma in Schistosoma mansoni infected mice." | 3.69 | Comparative effect of tiaprofenic acid and piroxicam alone and as adjuvants to praziquantel in Schistosoma mansoni infected mice. ( Hegazy, IH; Moussa, SM; Nassar, SH, 1997) |
| " The efficacy of BAPN, alone or in association with the anti-schistosomal drug, praziquantel (PZQ), was primarily assessed by measuring the reduction in liver and intestinal egg loads in murine schistosomiasis mansoni." | 3.68 | Experimental schistosomiasis mansoni: modulation of granulomas by inhibition of collagen cross-link formation. Preliminary report. ( Giboda, M; Julis, I; Vítovec, J; Zenka, J, 1992) |
| "We describe the parameters useful in evaluating the development of hepatic fibrosis in Schistosoma japonicum infection, as well as its improvement after treatment with praziquantel (PZQ)." | 3.68 | Serologic and ultrasonographic parameters of praziquantel treatment of hepatic fibrosis in Schistosoma japonicum infection. ( Irie, Y; Nara, T; Ohmae, H; Taguchi, H; Tanaka, M; Utsunomiya, H; Yasuraoka, K, 1991) |
| "The cellular and humoral immune responses of CF1 and C57BL/6 mice with schistosomiasis mansoni were evaluated before and after chemotherapeutic cure of their infections by praziquantel." | 3.67 | Effects of anti-schistosomal chemotherapy on immune responses, protection and immunity. I. Changes in cellular and humoral responses. ( Carter, CE; Colley, DG; Tawfik, AF, 1986) |
| " The effect of treatment with praziquantel at 8, 12, and 20 weeks postinfection on fibrosis was assessed by determination of total hepatic collagen content, ratio of type III/I + III collagen, granuloma volume, and histopathological examination of liver section." | 3.67 | Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni. ( Abdallah, NM; Botros, SS; el-Badrawy, NM; Hassanein, HI; Herbage, D; Nagy, FM, 1988) |
| "Cattle naturally infected with nasal schistosomiasis were treated with a single oral dose of praziquantel at 20 mg/kg body weight." | 3.67 | Efficacy of praziquantel against Schistosoma nasale infection in cattle. ( D'Souza, PE; Jagannath, MS; Prabhakar, KS; Prem, G; Rahman, SA; Sano, M, 1988) |
| "Schistosomiasis is one of the most prevalent helminthic infections worldwide." | 1.91 | Anti-angiogenic and anti-proliferative activity of ziziphus leaf extract as a novel potential therapeutic agent for reducing hepatic injury in experimental hamster schistosomiasis. ( Alghamdi, T; El-Refaei, MF; Salem, DA, 2023) |
| "Schistosomiasis is still a major health problem affecting nearly 250 million people worldwide and causes approximately 280,000 deaths per year." | 1.72 | Anti-inflammatory, antioxidant, anti-fibrotic and schistosomicidal properties of plumbagin in murine schistosomiasis. ( Abdel-Latif, M; Abuelsaad, ASA; Allam, GA; Bakery, HH; Elkenawy, AE; Khalil, RG, 2022) |
| "Curcumin-treated groups, with and without PZQ, resulted in higher significant Immunoreactivity score (IRS) for Bcl-2-associated X (BAX) and lower Interleukine- 17A (IL-17A), and Human epidermal growth factor (EGF), compared to the control." | 1.72 | Potentiality of curcumin on ISHAK scoring system and the expressions of BAX, IL-17A, and EGF in the treatment ofSchistosoma mansoni infection using Swiss albino mice. ( Abd-Elaal, AA; Amin, NM; El Saftawy, EA; El-Dardiry, MA; Negm, MSI, 2022) |
| " This study aimed to evaluate the role of Met as anti-schistosomal and anti-fibrotic agents alone or in combination with PZQ treatment." | 1.62 | An adjuvant effect of Metformin as an anti-fibrotic agent when administered with the anti-schistosomal Praziquantel in Schistosoma mansoni infected mice. ( El-Naggar, SA; El-Said, KS; Harras, SF; Salama, WM, 2021) |
| "Omeprazole is a proton pump inhibitor which is reported to have antiparasitic properties." | 1.51 | Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice. ( Abdel Ghaffar, AE; Alshenawy, HA; Elgendy, DI; Ellakany, AR, 2019) |
| "Schistosomiasis mansoni is considered one of the most common fibrotic diseases resulting from inflammation and deposition of fibrous tissue around parasitic eggs trapped in the liver, causing morbidity and mortality." | 1.48 | Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection. ( El-Sayed, SH; Mahmoud, SS; Negm, MSI; Raafat, A; Rizk, EMA; Sobhy, MMK, 2018) |
| " In the current work, the therapeutic efficacy of different limonin dosing protocols was evaluated in experimentally infected mice harboring Schistosoma mansoni (Egyptian strain) juvenile or adult stages." | 1.43 | Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice. ( Abdallah, KF; Abou-Ouf, EA; Aly, NS; El-Kholy, AA; Eraky, MA; Hamdan, DI; Hammam, OA; Kishik, SM; Moharam, AF; Rashed, GA, 2016) |
| "Praziquantel (PZQ) has shown some anti-schistosomal effect, but little information is available about the effect of PZQ-prolonged administration on granuloma formation around schistosome eggs." | 1.42 | Transdermal praziquantel administration attenuates hepatic granulomatosis in mice infected with Schistosoma japonicum. ( Bao-an, Y; Jiang-shan, D; Li-zhi, W; Xin-Sheng, Z; Yi, W, 2015) |
| " Taken together, these findings suggest that long term administration of ASU may result in a mild course of murine schistosomiasis and may be a promising complementary treatment to PZQ." | 1.38 | Evaluation of avocado/soybean unsaponifiable alone or concurrently with praziquantel in murine schistosomiasis. ( Soliman, MF, 2012) |
| "Praziquantel is an effective antischistosomal drug especially for adult worms." | 1.37 | Effect of praziquantel prolonged administration on granuloma formation around Schistosoma japonicum eggs in lung of sensitized mice. ( Huang, YX; Li, HJ; Liang, YS; Wang, TS; Wang, W; Xu, YL; Yin, XR; Yu, CX, 2011) |
| "Paragonimiasis is a food-borne zoonosis caused by a trematode of the genus Paragonimus(1,2)." | 1.37 | [Pulmonary paragonimiasis]. ( Fortes-Alen, J; Gómez-Escolar, PF; Gómez-Seco, J; Presa-Abos, T; Rodríguez-Guzmán, MJ; Rodríguez-Nieto, MJ, 2011) |
| "Pentoxifylline (PTX) was proved to exert both anti-inflammatory and anti-fibrotic effects, and was used therapeutically in this experimental model to investigate its role alone or with praziquantel (PZQ) in Schistosoma mansoni-infected mice, and to explore its impact on the tissue expression of transforming growth factor-beta1 (TGF-beta1)." | 1.34 | Pharmacodynamics of pentoxifylline and/or praziquantel in murine schistosomiasis mansoni. ( El-Lakkany, N; Nosseir, M, 2007) |
| " These effects were more pronounced with dosing regimens launched before the time of oviposition." | 1.32 | Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice. ( Botros, S; Hammam, O; Holý, A; William, S; Zídek, Z, 2003) |
| "Treatment with ibuprofen or naproxen either alone or in combination with praziquantel or praziquantel alone reduced significantly the granuloma diameters." | 1.31 | Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis. ( Mahmoud, MR; Nosseir, MM; Zoheiry, MM, 2002) |
| " In infected rabbits treated repeatedly with the above-mentioned dosage of Art at 2-wk intervals (i." | 1.29 | [Pathological changes in the livers of rabbits infected with schistosome cercariae and treated with artemether or praziquantel in the early stage of infection]. ( Xiao, S; Yang, Y; Zhang, C, 1995) |
| "In praziquantel-treated mice, the reduction in the per cent resistance was accompanied by a diminution in the size of hepatic granulomata and its in vivo correlate the delayed foot pad swelling." | 1.28 | Effect of specific chemotherapy on the immune response and resistance to reinfection in experimental Schistosomiasis mansoni. ( Azab, ME; Botros, SS; el-Garem, AA; el-Nahal, HM; Hassan, SI; Shaker, ZA, 1990) |
| "In praziquantel-treated mice (500 mg/kg for 2 days orally), the reduction in the percent resistance (45." | 1.28 | Levamisole restored the compromised state of immunity after specific chemotherapy in experimental schistosomiasis mansoni. ( Azab, ME; Botros, SS; el-Garem, A; el-Nahal, HM; Hassan, SI; Shaker, ZA, 1989) |
| "Mice treated with praziquantel showed a prompt decrease in S." | 1.27 | Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. ( Dunn, MA; Girgis, NI; Ishak, EA; Khayyal, MT; Mansour, MM; Morcos, SH; Saleh, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (14.74) | 18.7374 |
| 1990's | 20 (21.05) | 18.2507 |
| 2000's | 15 (15.79) | 29.6817 |
| 2010's | 31 (32.63) | 24.3611 |
| 2020's | 15 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Atwa, MTM | 1 |
| Abd-Elrazek, AM | 1 |
| Salem, NIS | 1 |
| El Saftawy, EA | 1 |
| El-Dardiry, MA | 1 |
| Abd-Elaal, AA | 1 |
| Negm, MSI | 2 |
| Amin, NM | 1 |
| Membe Femoe, U | 1 |
| Boukeng Jatsa, H | 1 |
| Greigert, V | 1 |
| Brunet, J | 1 |
| Cannet, C | 1 |
| Kenfack, MC | 1 |
| Gipwe Feussom, N | 1 |
| Kadji Fassi, JB | 1 |
| Tienga Nkondo, E | 1 |
| Abou-Bacar, A | 1 |
| Pfaff, AW | 1 |
| Dimo, T | 1 |
| Kamtchouing, P | 1 |
| Tchuem Tchuenté, LA | 1 |
| Dos Reis, LFC | 1 |
| Cerdeira, CD | 1 |
| Gagliano, GS | 1 |
| de Figueiredo, ABT | 1 |
| Ferreira, JH | 1 |
| Castro, AP | 2 |
| Souza, RLM | 3 |
| Marques, MJ | 3 |
| Bakery, HH | 1 |
| Allam, GA | 1 |
| Abuelsaad, ASA | 1 |
| Abdel-Latif, M | 1 |
| Elkenawy, AE | 1 |
| Khalil, RG | 1 |
| Hamdan, ZK | 1 |
| Soliman, MI | 1 |
| Taha, HA | 1 |
| Khalil, MMH | 1 |
| Nigm, AH | 1 |
| Alghamdi, T | 1 |
| Salem, DA | 1 |
| El-Refaei, MF | 1 |
| Shen, J | 1 |
| Wang, L | 1 |
| Peng, M | 1 |
| Liu, Z | 1 |
| Zhang, B | 1 |
| Zhou, T | 1 |
| Sun, X | 1 |
| Wu, Z | 1 |
| Ellakany, AR | 1 |
| Elgendy, DI | 1 |
| Alshenawy, HA | 1 |
| Abdel Ghaffar, AE | 1 |
| Hasby Saad, MA | 1 |
| El-Anwar, N | 1 |
| Miranda, VHS | 1 |
| Gomes, TR | 1 |
| Eller, DE | 1 |
| Ferraz, LCN | 1 |
| Chaves, AT | 1 |
| Bicalho, KA | 1 |
| Silva, CEC | 1 |
| Birbrair, A | 1 |
| Pascoal Xavier, MA | 1 |
| de Goes, AM | 1 |
| Corrêa-Oliveira, R | 1 |
| Alves, ÉAR | 1 |
| Bozzi, A | 1 |
| Eissa, MM | 2 |
| El-Azzouni, MZ | 2 |
| El-Khordagui, LK | 2 |
| Abdel Bary, A | 1 |
| El-Moslemany, RM | 2 |
| Abdel Salam, SA | 1 |
| Santos, MP | 1 |
| Gonçalves-Santos, E | 1 |
| Gonçalves, RV | 2 |
| Santos, EC | 1 |
| Campos, CC | 2 |
| Bastos, DSS | 1 |
| Novaes, RD | 2 |
| Abou-El-Naga, IF | 1 |
| El-Temsahy, MM | 1 |
| Mogahed, NMFH | 1 |
| Sheta, E | 1 |
| Makled, S | 1 |
| Ibrahim, EI | 1 |
| Silva, JCS | 1 |
| Lins, CRB | 1 |
| Lacerda, SS | 1 |
| Ramos, REM | 1 |
| Araújo, HDA | 1 |
| Melo-Junior, MR | 1 |
| Alves, LC | 1 |
| Brayner, FA | 1 |
| Nunes, IS | 1 |
| Melo, FL | 1 |
| Carvalho, BM | 1 |
| Abd El Wahab, WM | 1 |
| El-Badry, AA | 1 |
| Mahmoud, SS | 3 |
| El-Badry, YA | 1 |
| El-Badry, MA | 1 |
| Hamdy, DA | 1 |
| Salama, WM | 1 |
| El-Naggar, SA | 1 |
| Harras, SF | 1 |
| El-Said, KS | 1 |
| Diabaté, I | 1 |
| Karama, H | 1 |
| Bazolo, G | 1 |
| Bâ, A | 1 |
| Thiam, M | 1 |
| Abd El-Aal, NF | 1 |
| Hamza, RS | 1 |
| Magdy, M | 1 |
| Sobhy, MMK | 1 |
| El-Sayed, SH | 1 |
| Rizk, EMA | 1 |
| Raafat, A | 1 |
| El-Refai, SA | 1 |
| Atia, AF | 1 |
| Mahmoud, SF | 1 |
| Dias, MV | 1 |
| Souza-Silva, TG | 1 |
| El Nokrashy, A | 1 |
| Abou Samra, W | 1 |
| Sobeih, D | 1 |
| Lamin, A | 1 |
| Hashish, A | 1 |
| Tarshouby, S | 1 |
| Lightman, S | 1 |
| Sewelam, A | 1 |
| Issa, YA | 1 |
| El Achy, SN | 1 |
| Mady, RF | 1 |
| Allam, G | 1 |
| Eweas, AF | 1 |
| Abuelsaad, AS | 1 |
| Farid, A | 1 |
| Malek, AA | 1 |
| Rabie, I | 1 |
| Helmy, A | 1 |
| El Amir, AM | 1 |
| Mohamed, AH | 1 |
| Osman, GY | 1 |
| Salem, TA | 1 |
| Elmalawany, AM | 1 |
| Mahmoud, TY | 1 |
| Rizk, SM | 1 |
| Maghraby, AS | 1 |
| Shaheen, AA | 1 |
| Li-zhi, W | 1 |
| Xin-Sheng, Z | 1 |
| Jiang-shan, D | 1 |
| Yi, W | 1 |
| Bao-an, Y | 1 |
| Thiam, I | 1 |
| Doh, K | 1 |
| Seck, M | 1 |
| Kammoun, C | 1 |
| Woto-Gaye, G | 1 |
| Yepes, E | 1 |
| Varela-M, RE | 1 |
| López-Abán, J | 1 |
| Rojas-Caraballo, J | 1 |
| Muro, A | 1 |
| Mollinedo, F | 1 |
| Coron, N | 1 |
| Le Govic, Y | 1 |
| Kettani, S | 1 |
| Pihet, M | 1 |
| Hemery, S | 1 |
| de Gentile, L | 1 |
| Chabasse, D | 1 |
| Chuah, C | 1 |
| Jones, MK | 1 |
| McManus, DP | 1 |
| Nawaratna, SK | 1 |
| Burke, ML | 1 |
| Owen, HC | 1 |
| Ramm, GA | 1 |
| Gobert, GN | 1 |
| Parikh, ND | 1 |
| Gurung, A | 1 |
| Chaptini, L | 1 |
| Ramadan, AA | 1 |
| Eraky, MA | 1 |
| El-Kholy, AA | 1 |
| Rashed, GA | 1 |
| Hammam, OA | 2 |
| Moharam, AF | 1 |
| Abou-Ouf, EA | 1 |
| Aly, NS | 1 |
| Kishik, SM | 1 |
| Abdallah, KF | 1 |
| Hamdan, DI | 1 |
| Helmy, MM | 1 |
| Fahmy, ZH | 1 |
| Aly, IR | 1 |
| Hendawy, MA | 1 |
| Ali, E | 1 |
| Hassan, E | 1 |
| Nosseir, MM | 3 |
| Gómez-Seco, J | 1 |
| Rodríguez-Guzmán, MJ | 1 |
| Rodríguez-Nieto, MJ | 1 |
| Gómez-Escolar, PF | 1 |
| Presa-Abos, T | 1 |
| Fortes-Alen, J | 1 |
| Crosby, A | 1 |
| Jones, FM | 1 |
| Kolosionek, E | 1 |
| Southwood, M | 1 |
| Purvis, I | 1 |
| Soon, E | 1 |
| Butrous, G | 1 |
| Dunne, DE | 1 |
| Morrell, NW | 1 |
| Huang, YX | 1 |
| Xu, YL | 1 |
| Yu, CX | 1 |
| Li, HJ | 1 |
| Yin, XR | 1 |
| Wang, TS | 1 |
| Wang, W | 1 |
| Liang, YS | 2 |
| El-Lakkany, NM | 2 |
| El-Maadawy, W | 1 |
| Ain-Shoka, A | 1 |
| Badawy, A | 1 |
| Hammam, O | 2 |
| Ebeid, F | 1 |
| el-Din, SH | 1 |
| Sabra, AN | 1 |
| Chen, BL | 1 |
| Zhang, GY | 1 |
| Wang, SP | 1 |
| Li, Q | 1 |
| Xu, MH | 1 |
| Shen, YM | 1 |
| Yan, L | 1 |
| Gu, H | 1 |
| Li, J | 1 |
| Huang, YL | 1 |
| Mu, YB | 1 |
| Soliman, MF | 1 |
| de Lima Aires, A | 1 |
| de Azevedo Albuquerque, MC | 1 |
| Silva, RA | 1 |
| Schirato, GV | 1 |
| de Pontes Filho, NT | 1 |
| de Araújo, SB | 1 |
| Souza, VM | 1 |
| Costa, VM | 1 |
| Malagueño, E | 1 |
| Otte, WM | 1 |
| Singla, M | 1 |
| Sander, JW | 1 |
| Singh, G | 1 |
| Coles, GC | 1 |
| Dai, JR | 1 |
| Zhu, YC | 1 |
| Doenhoff, MJ | 1 |
| Hassan, SI | 3 |
| Ali, I | 1 |
| Nessim, NG | 3 |
| Amer, NM | 1 |
| Abd el Kader el Khafif, M | 1 |
| Ashour, A | 1 |
| el Mohandes, M | 1 |
| William, S | 2 |
| Guirguis, F | 1 |
| Traore, HA | 1 |
| Maiga, MY | 1 |
| Sogodogo, S | 1 |
| Dembele, M | 1 |
| Sidibe, TA | 1 |
| Diallo, D | 1 |
| Diallo, AN | 1 |
| Guindo, A | 1 |
| Pichard, E | 1 |
| Doumbo, O | 1 |
| Botros, S | 3 |
| Zídek, Z | 2 |
| Holý, A | 1 |
| Hanallah, S | 1 |
| El-Lakkany, N | 2 |
| Mahmoud, S | 2 |
| Mousa, M | 1 |
| Spicher, VM | 1 |
| Genin, B | 1 |
| Jordan, AR | 1 |
| Rubbia-Brandt, L | 1 |
| Le Coultre, C | 1 |
| Silva, IM | 1 |
| Thiengo, R | 1 |
| Conceição, MJ | 1 |
| Rey, L | 1 |
| Lenzi, HL | 1 |
| Pereira Filho, E | 1 |
| Ribeiro, PC | 1 |
| Andrade, ZA | 2 |
| Baptista, AP | 1 |
| Santana, TS | 1 |
| Nosseir, M | 1 |
| Botros, SS | 9 |
| Mahmoud, MR | 3 |
| Moussa, MM | 1 |
| Pistone, T | 1 |
| Ezzedine, K | 1 |
| Accoceberry, I | 1 |
| Receveur, MC | 1 |
| Juguet, F | 1 |
| Malvy, D | 1 |
| Yang, YQ | 1 |
| Yang, HZ | 1 |
| Zhang, CW | 1 |
| Metwally, AA | 4 |
| Khayyal, MT | 5 |
| Mehlhorn, H | 1 |
| Frenkel, JK | 1 |
| Andrews, P | 1 |
| Thomas, H | 1 |
| Giboda, M | 3 |
| Jacobs, P | 1 |
| Smith, JM | 2 |
| Miller, SC | 1 |
| Kresina, TF | 1 |
| He, Q | 1 |
| Degli Esposti, S | 1 |
| Zern, MA | 1 |
| Zhang, C | 1 |
| Yang, Y | 1 |
| Xiao, S | 1 |
| Prichard, RK | 1 |
| Montasser, MF | 1 |
| Younis, TA | 1 |
| Fahmy, IA | 1 |
| Sabry, NM | 1 |
| el-Monayerhy, MS | 1 |
| Rashad, MS | 1 |
| el-Fakahany, AF | 1 |
| Abdalla, KF | 1 |
| el-Hady, HM | 1 |
| Abd el-Aziz, SM | 1 |
| Afifi, LM | 1 |
| Cox, TM | 1 |
| Cheever, AM | 1 |
| Moustafa, FE | 1 |
| Hamouda, MM | 1 |
| el-Shazly, AM | 1 |
| Sheha, G | 1 |
| Hamid, S | 1 |
| el-Naggar, HM | 1 |
| Habib, FS | 1 |
| Morsy, TA | 1 |
| Hassan, S | 1 |
| Ibrahim, A | 1 |
| Masek, K | 1 |
| Johansen, MV | 1 |
| Monrad, J | 1 |
| Christensen, NO | 1 |
| Lindberg, R | 1 |
| Doughty, BL | 1 |
| Shaker, ZA | 3 |
| Akl, MM | 1 |
| Sharmy, R | 1 |
| Diab, TM | 1 |
| Hassanein, HI | 2 |
| Grenard, P | 1 |
| Blanquier, B | 1 |
| Ricard-Blum, S | 1 |
| Hegazy, IH | 1 |
| Nassar, SH | 1 |
| Moussa, SM | 1 |
| Noya, O | 1 |
| Gonzalez-Rico, S | 1 |
| Rodriguez, R | 1 |
| Arrechedera, H | 1 |
| Patarroyo, ME | 1 |
| Alarcon de Noya, B | 1 |
| Mola, PW | 1 |
| Farah, IO | 2 |
| Kariuki, TM | 1 |
| Nyindo, M | 1 |
| Blanton, RE | 1 |
| King, CL | 1 |
| Demerdash, Z | 1 |
| Johansson, M | 1 |
| Lövgren-Bengtson, K | 1 |
| Hau, J | 1 |
| Zoheiry, MM | 1 |
| Zenka, J | 1 |
| Julis, I | 1 |
| Vítovec, J | 1 |
| Saleh, S | 2 |
| Ohmae, H | 1 |
| Tanaka, M | 1 |
| Nara, T | 1 |
| Utsunomiya, H | 1 |
| Taguchi, H | 1 |
| Irie, Y | 1 |
| Yasuraoka, K | 1 |
| el-Nahal, HM | 2 |
| Azab, ME | 2 |
| el-Garem, AA | 1 |
| Mao, SC | 1 |
| Ye, XC | 1 |
| Liu, JX | 1 |
| Zhang, JW | 1 |
| el-Garem, A | 1 |
| Tawfik, AF | 1 |
| Carter, CE | 1 |
| Colley, DG | 1 |
| el-Badrawy, N | 1 |
| el-Badrawy, NM | 1 |
| Nagy, FM | 1 |
| Abdallah, NM | 1 |
| Herbage, D | 1 |
| Rahman, SA | 1 |
| Sano, M | 1 |
| Jagannath, MS | 1 |
| Prabhakar, KS | 1 |
| D'Souza, PE | 1 |
| Prem, G | 1 |
| Bychkov, VG | 1 |
| Molokova, OA | 1 |
| Zuevskiĭ, VP | 1 |
| Morcos, SH | 1 |
| Mansour, MM | 1 |
| Ishak, EA | 1 |
| Girgis, NI | 1 |
| Dunn, MA | 1 |
| Rainsford, KD | 1 |
| Lüttges, J | 1 |
| Koransky, K | 1 |
2 reviews available for praziquantel and Granulomas
| Article | Year |
|---|---|
[Appendicitis schistosomiasis: unusual lesion about two cases in Senegal].
Topics: Abdomen, Acute; Adolescent; Animals; Anthelmintics; Appendectomy; Appendicitis; Emergencies; Endemic | 2015 |
Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis.
Topics: Adolescent; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Calcinosis; Child; Child, Preschoo | 2013 |
93 other studies available for praziquantel and Granulomas
| Article | Year |
|---|---|
Dandelion (Taraxacum officinale) Improves the Therapeutic Efficiency of Praziquantel in Experimental Schistosomiasis.
Topics: Animals; Anthelmintics; Granuloma; Liver; Liver Diseases; Mice; Plant Extracts; Praziquantel; Schist | 2022 |
Potentiality of curcumin on ISHAK scoring system and the expressions of BAX, IL-17A, and EGF in the treatment ofSchistosoma mansoni infection using Swiss albino mice.
Topics: Animals; Anthelmintics; bcl-2-Associated X Protein; Curcumin; Epidermal Growth Factor; Granuloma; In | 2022 |
Pathological and immunological evaluation of different regimens of praziquantel treatment in a mouse model of Schistosoma mansoni infection.
Topics: Animals; Anthelmintics; Disease Models, Animal; Granuloma; Mice; Praziquantel; Schistosoma mansoni; | 2022 |
Alternate-day fasting, a high-sucrose/caloric diet and praziquantel treatment influence biochemical and behavioral parameters during Schistosoma mansoni infection in male BALB/c mice.
Topics: Animals; Anthelmintics; Fasting; Glucose; Granuloma; Liver; Male; Mice; Mice, Inbred BALB C; Praziqu | 2022 |
Anti-inflammatory, antioxidant, anti-fibrotic and schistosomicidal properties of plumbagin in murine schistosomiasis.
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents; Antioxidants; Catalase; Female; Granuloma; Immunog | 2022 |
Antischistosomal effects of green and chemically synthesized silver nanoparticles: In vitro and in vivo murine model.
Topics: Animals; Anthelmintics; Disease Models, Animal; Granuloma; Metal Nanoparticles; Mice; Praziquantel; | 2023 |
Anti-angiogenic and anti-proliferative activity of ziziphus leaf extract as a novel potential therapeutic agent for reducing hepatic injury in experimental hamster schistosomiasis.
Topics: Animals; Anthelmintics; Antioxidants; Cricetinae; Granuloma; Ki-67 Antigen; Liver; Plant Extracts; P | 2023 |
Recombinant Sj16 protein with novel activity alleviates hepatic granulomatous inflammation and fibrosis induced by Schistosoma japonicum associated with M2 macrophages in a mouse model.
Topics: Animals; Anthelmintics; Disease Models, Animal; Fibrosis; Granuloma; Helminth Proteins; Immunologic | 2019 |
Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
Topics: Animals; Drug Therapy, Combination; Granuloma; Liver Cirrhosis; Male; Mice; Omeprazole; Parasite Egg | 2019 |
Bevacizumab as a potential anti-angiogenic therapy in schistosomiasis: A double-edged, but adjustable weapon.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Chronic Disease; Granuloma; Liver Diseases; Male; Mic | 2020 |
Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment.
Topics: Adipose Tissue; Animals; Cell- and Tissue-Based Therapy; Cytokines; Disease Models, Animal; Granulom | 2020 |
Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
Topics: Animals; Anthelmintics; Disease Models, Animal; Drug Carriers; Drug Combinations; Granuloma; Lipids; | 2020 |
Doxycycline aggravates granulomatous inflammation and lung microstructural remodeling induced by Schistosoma mansoni infection.
Topics: Airway Remodeling; Animals; Anthelmintics; Cytokines; Disease Models, Animal; Doxycycline; Granuloma | 2021 |
Effect of celecoxib against different developmental stages of experimental Schistosoma mansoni infection.
Topics: Administration, Oral; Animals; Anthelmintics; Apoptosis; Celecoxib; Disease Models, Animal; Female; | 2021 |
In vitro and in vivo effects of P-MAPA immunomodulator on schistosomiasis.
Topics: Animals; Female; Granuloma; Humans; Immunologic Factors; Intestines; Linoleic Acids; Liver; Male; Mi | 2021 |
Ginger (Zingiber Officinale)-derived nanoparticles in Schistosoma mansoni infected mice: Hepatoprotective and enhancer of etiological treatment.
Topics: Administration, Oral; Animals; Anthelmintics; Drug Therapy, Combination; Granuloma; Liver; Male; Mef | 2021 |
An adjuvant effect of Metformin as an anti-fibrotic agent when administered with the anti-schistosomal Praziquantel in Schistosoma mansoni infected mice.
Topics: Adjuvants, Pharmaceutic; Animals; Anthelmintics; Diabetes Mellitus, Type 2; Fibrosis; Granuloma; Mal | 2021 |
[Pseudotumoral genital schistosomiasis].
Topics: Anthelmintics; Child; Female; Granuloma; Humans; Praziquantel; Schistosomiasis haematobia; Vulva; Vu | 2017 |
Anti-angiogenic and anti-lymphangiogenic role of praziquantel and artemether in experimental mansoniasis.
Topics: Animals; Artemether; Artemisinins; Female; Granuloma; Liver Diseases; Mice; Praziquantel; Schistosom | 2017 |
Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
Topics: Acute Disease; Animals; Anthelmintics; Biomphalaria; Chronic Disease; Collagen; Female; Genistein; G | 2018 |
Effects of Callistemon citrinus aqueous extract on prepatent and patent infections with Schistosoma mansoni in experimentally infected mice.
Topics: Animals; Drug Therapy, Combination; Granuloma; Intestines; Liver; Male; Mice; Mice, Inbred BALB C; M | 2019 |
Doxycycline hyclate: A schistosomicidal agent in vitro with immunomodulatory potential on granulomatous inflammation in vivo.
Topics: Animals; Antimalarials; Cells, Cultured; Disease Models, Animal; Doxycycline; Granuloma; Humans; Imm | 2019 |
Treatment of presumed trematode-induced granulomatous anterior uveitis among children in rural areas of Egypt.
Topics: Adolescent; Animals; Antiprotozoal Agents; Child; Child, Preschool; Combined Modality Therapy; Corne | 2019 |
Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model.
Topics: Actins; Animals; Anthelmintics; Cannabinoid Receptor Antagonists; Drug Therapy, Combination; Granulo | 2019 |
In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Granuloma; Humans; Liver; Male; Mice; Oxyquinolin | 2013 |
Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile.
Topics: Animals; Cysteine Proteinase Inhibitors; Disease Models, Animal; Granuloma; Intestines; Liver; Male; | 2013 |
The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Anthelmintics; Aspartate Aminotransferases; Blo | 2014 |
Propolis enhances the effectiveness of praziquantel in experimental schistosomiasis: biochemical and histopathological study.
Topics: Animals; Anti-Infective Agents; Blood Proteins; Drug Therapy, Combination; Glutathione; Granuloma; I | 2014 |
Transdermal praziquantel administration attenuates hepatic granulomatosis in mice infected with Schistosoma japonicum.
Topics: Administration, Cutaneous; Animals; Anthelmintics; Drug Evaluation, Preclinical; Female; Granuloma; | 2015 |
Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel.
Topics: Animals; Anthelmintics; Cytokines; Gene Expression Regulation; Granuloma; Inflammation; Mice; Phosph | 2015 |
Early Detection of Schistosoma Egg-Induced Pulmonary Granulomas in a Returning Traveler.
Topics: Animals; Benin; France; Granuloma; Humans; Lung Diseases, Parasitic; Male; Ovum; Praziquantel; Schis | 2016 |
Characterising granuloma regression and liver recovery in a murine model of schistosomiasis japonica.
Topics: Animals; Anthelmintics; Disease Models, Animal; Eosinophils; Female; Granuloma; Immunohistochemistry | 2016 |
Images of the Month: Schistosomiasis as a Solitary Sigmoid Nodule.
Topics: Adult; Anthelmintics; Eggs; Granuloma; Humans; Male; Praziquantel; Schistosomiasis; Sigmoid Diseases | 2016 |
Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni.
Topics: Administration, Oral; Animals; Disease Models, Animal; Drug Repositioning; Granuloma; Liver; Mice; N | 2016 |
Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice.
Topics: Administration, Oral; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resist | 2016 |
Schistosoma mansoni: effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel.
Topics: Animals; Anthelmintics; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Dietary Supplements; Dr | 2009 |
Immunological and parasitological parameters after treatment with dexamethasone in murine Schistosoma mansoni.
Topics: Adjuvants, Immunologic; Animals; Anthelmintics; Cytokines; Dexamethasone; Dioxoles; Drug Therapy, Co | 2010 |
[Pulmonary paragonimiasis].
Topics: Adult; Animals; Anthelmintics; Antitubercular Agents; Caulobacteraceae; Delayed Diagnosis; Ecuador; | 2011 |
Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis.
Topics: Animals; Anthelmintics; Blood Pressure; Blood Vessels; Cytokines; Down-Regulation; Female; Granuloma | 2011 |
Effect of praziquantel prolonged administration on granuloma formation around Schistosoma japonicum eggs in lung of sensitized mice.
Topics: Animals; Anthelmintics; Granuloma; Histocytochemistry; Humans; Leukocytes; Lung; Mice; Mice, Inbred | 2011 |
Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anthelmintics; Disease Models, Animal; Drug Therap | 2011 |
Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female | 2011 |
The combined treatment of praziquantel with osteopontin immunoneutralization reduces liver damage in Schistosoma japonicum-infected mice.
Topics: Animals; Antibodies, Neutralizing; Arteriosclerosis; Drug Therapy, Combination; Female; Granuloma; I | 2012 |
Evaluation of avocado/soybean unsaponifiable alone or concurrently with praziquantel in murine schistosomiasis.
Topics: Administration, Oral; Animals; Anthelmintics; Cytokines; Disease Models, Animal; Drug Therapy, Combi | 2012 |
Immunohistopathological changes in murine Schistosomiasis mansoni under the influence of N-acetyl-L-cysteine.
Topics: Acetylcysteine; Administration, Oral; Animals; Anthelmintics; Anti-Inflammatory Agents; Disease Mode | 2012 |
Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Topics: Animals; Anthelmintics; Drug Resistance; Female; Granuloma; Liver Diseases, Parasitic; Male; Mice; M | 2002 |
Treatment of acute schistosomiasis mansoni with praziquantel and an antifibrotic agent in mice. Maintenance of resistance to infection.
Topics: Acute Disease; Aminopropionitrile; Animals; Antiplatyhelmintic Agents; Drug Resistance; Fibrosis; Gr | 2003 |
Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection.
Topics: Animals; Drug Therapy, Combination; Female; Granuloma; Liver; Male; Mebendazole; Mice; Parasite Egg | 2003 |
[Importance of hepatic bilharziasis in liver pathologies in the internal medicine department of the National Hospital of Point "G", Bamako-Mali].
Topics: Adolescent; Adult; Aged; Anthelmintics; Biopsy; Child; Female; Granuloma; Hepatomegaly; Hospital Dep | 1996 |
Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice.
Topics: Adenine; Animals; Female; Fertility; Granuloma; Intestines; Liver; Male; Mice; Organophosphonates; O | 2003 |
Altered immunoglobulin isotype profile and anti-immature worm surface immunoglobulins in mice harboring a praziquantel-resistant Schistosoma mansoni isolate.
Topics: Animals; Anthelmintics; Antibodies, Helminth; Disease Models, Animal; Drug Resistance; Granuloma; Im | 2003 |
Peritoneal schistosomiasis: an unusual laparoscopic finding.
Topics: Adolescent; Appendicitis; Diagnosis, Differential; Granuloma; Humans; Incidental Findings; Laparosco | 2004 |
Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa.
Topics: Adult; Africa; Animals; Anthelmintics; Brazil; Cystoscopy; Granuloma; Humans; Male; Middle Aged; Mil | 2005 |
Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis.
Topics: Animals; Anthelmintics; Chronic Disease; Disease Models, Animal; Female; Granuloma; Humans; Liver Ci | 2006 |
Pharmacodynamics of pentoxifylline and/or praziquantel in murine schistosomiasis mansoni.
Topics: Animals; Anthelmintics; Disease Models, Animal; Granuloma; Male; Mice; Pentoxifylline; Praziquantel; | 2007 |
Immunohistopathological and biochemical changes in Schistosoma mansoni-infected mice treated with artemether.
Topics: Animals; Apoptosis; Artemether; Artemisinins; Granuloma; Histocytochemistry; Liver; Liver Function T | 2007 |
Ectopic cutaneous schistosomiasis-perigenital infiltrative granulomata in a 34-year-old French pregnant woman.
Topics: Administration, Oral; Adult; Anal Canal; Anthelmintics; Diagnosis, Differential; Female; France; Gra | 2008 |
[Effects of pyquiton on pulmonary S. japonicum egg granulomas in sensitized mice].
Topics: Animals; Female; Granuloma; Isoquinolines; Levamisole; Lung Diseases, Parasitic; Mice; Ovum; Praziqu | 1984 |
The immunological aspects of praziquantel in unsensitized mice with experimentally induced schistosome pulmonary granuloma.
Topics: Animals; Antibody Formation; Antimony Potassium Tartrate; Cell Migration Inhibition; Granuloma; Hype | 1984 |
Light and electron microscopic studies on Schistosoma mansoni Granulomas of mouse livers following treatment with praziquantel.
Topics: Animals; Female; Granuloma; Isoquinolines; Liver; Liver Diseases; Mice; Ovum; Praziquantel; Schistos | 1982 |
Immune response of mice infected with Schistosoma mansoni is modulated by antifibrotic treatment.
Topics: Aminopropionitrile; Animals; Antiplatyhelmintic Agents; Drug Therapy, Combination; Female; Granuloma | 1995 |
Hepatic fibrosis and gene expression changes induced by praziquantel treatment during immune modulation of Schistosoma japonicum infection.
Topics: Animals; Chemotherapy, Cancer, Regional Perfusion; Chronic Disease; Collagen; Extracellular Matrix; | 1993 |
[Pathological changes in the livers of rabbits infected with schistosome cercariae and treated with artemether or praziquantel in the early stage of infection].
Topics: Animals; Artemether; Artemisinins; Female; Granuloma; Liver; Male; Praziquantel; Rabbits; Schistosom | 1995 |
Reduction in tissue egg load and maintenance of resistance to challenge in mice infected with Schistosoma mansoni, following combined treatment with praziquantel and an antifibrotic agent.
Topics: Aminopropionitrile; Animals; Drug Therapy, Combination; Feces; Female; Granuloma; Intestines; Liver; | 1994 |
Histopathological evidences for the antifibrogenic effect of colchicine in schistosomiasis mansoni in mice.
Topics: Animals; Colchicine; Drug Therapy, Combination; Granuloma; Liver; Liver Cirrhosis; Mice; Praziquante | 1994 |
The effect of praziquantel treatment on the liver functions, worm burden, and granuloma size using two drug regimen in murine Schistosoma mansoni infection.
Topics: Animals; Female; Granuloma; Liver; Male; Mice; Praziquantel; Schistosoma mansoni; Schistosomiasis ma | 1993 |
Regression of hepatic lesions after treatment of Schistosoma mansoni or Schistosoma japonicum infection in mice: a comparative study.
Topics: Animals; Collagen; Granuloma; Hydroxyproline; Liver; Lung; Mice; Praziquantel; Schistosoma japonicum | 1993 |
Effect of anti-schistosomal treatment on schistosomal hepatic pathology: an experimental study in Syrian golden hamsters.
Topics: Animals; Antiplatyhelmintic Agents; Biomphalaria; Blood Proteins; Cricetinae; Granuloma; Liver; Meso | 1996 |
Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Antibody Formation; Antiplatyhelmintic Agents; Dipeptid | 1996 |
Experimental Schistosoma bovis infection in goats: pathological consequences of praziquantel treatment.
Topics: Animals; Antiplatyhelmintic Agents; Female; Goats; Granuloma; Intestines; Liver; Liver Diseases; Lym | 1996 |
Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Female; Granuloma; Immune Tolerance; Immunoglobul | 1996 |
Urinary excretion of the collagen cross-link pyridinoline increases during liver fibrogenesis.
Topics: Amino Acids; Animals; Antiplatyhelmintic Agents; Chromatography, High Pressure Liquid; Chronic Disea | 1997 |
Comparative effect of tiaprofenic acid and piroxicam alone and as adjuvants to praziquantel in Schistosoma mansoni infected mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclic AMP; Dinoprostone; Drug Therapy, Combinatio | 1997 |
Schistosoma mansoni infection in owl monkeys (Aontus nancymai): evidence for the early elimination of adult worms.
Topics: Animals; Aotidae; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Feces; Granuloma; Hemat | 1998 |
Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Cytokines; Disease Models, Animal; Feces; Granulo | 1999 |
Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
Topics: Animals; Body Burden; Enzyme-Linked Immunosorbent Assay; Granuloma; Immunity, Cellular; Immunoglobul | 2000 |
Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Cells, Cultured; Concanavalin A; Culture Media; C | 2000 |
Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Helminth; Drug Therapy, Combination; G | 2002 |
Experimental schistosomiasis mansoni: modulation of granulomas by inhibition of collagen cross-link formation. Preliminary report.
Topics: Aminopropionitrile; Animals; Collagen; Drug Therapy, Combination; Female; Granuloma; Intestinal Dise | 1992 |
Schistosoma mansoni: angiotensin converting enzyme activity in mice under the influence of praziquantel and/or captopril.
Topics: Animals; Captopril; Drug Therapy, Combination; Granuloma; Intestines; Liver; Liver Diseases, Parasit | 1991 |
Serologic and ultrasonographic parameters of praziquantel treatment of hepatic fibrosis in Schistosoma japonicum infection.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bile Acids and Salts; Blood Pressure; Gr | 1991 |
Effect of specific chemotherapy on the immune response and resistance to reinfection in experimental Schistosomiasis mansoni.
Topics: Animals; Antibody Formation; Granuloma; Liver Diseases; Mice; Praziquantel; Schistosomiasis mansoni; | 1990 |
[CT brain scanning in the diagnosis and localisation of cerebral schistosomiasis].
Topics: Adolescent; Adult; Brain; Brain Diseases; Child; Female; Granuloma; Humans; Male; Middle Aged; Prazi | 1989 |
Levamisole restored the compromised state of immunity after specific chemotherapy in experimental schistosomiasis mansoni.
Topics: Adjuvants, Immunologic; Animals; Drug Therapy, Combination; Granuloma; Hypersensitivity, Delayed; Hy | 1989 |
Effects of anti-schistosomal chemotherapy on immune responses, protection and immunity. I. Changes in cellular and humoral responses.
Topics: Animals; Antibodies; Antibody Formation; Female; Granuloma; Hypersensitivity, Delayed; Immunity; Imm | 1986 |
Study of some immunopharmacological properties of praziquantel in experimental schistosomiasis mansoni.
Topics: Animals; Antigen-Antibody Reactions; Fluorescent Antibody Technique; Granuloma; Hypersensitivity, De | 1986 |
Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni.
Topics: Animals; Collagen; Electrophoresis, Polyacrylamide Gel; Granuloma; Liver; Liver Cirrhosis; Male; Mic | 1988 |
Comparative effect of tiaprofenic acid and piroxicam alone and as adjuvants to antibilharzial therapy on pulmonary granuloma in unsensitized mice.
Topics: Animals; Drug Therapy, Combination; Granuloma; Hypersensitivity, Delayed; Lung Diseases; Mice; Pirox | 1988 |
Efficacy of praziquantel against Schistosoma nasale infection in cattle.
Topics: Animals; Cattle; Cattle Diseases; Female; Granuloma; Male; Nose Diseases; Parasite Egg Count; Praziq | 1988 |
[Granulomatous inflammation of the liver in opisthorchiasis].
Topics: Animals; Cricetinae; Dimethylnitrosamine; Female; Granuloma; Hydrocortisone; Liver; Mesocricetus; Op | 1987 |
Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis.
Topics: Animals; Collagen; Granuloma; Hydroxyproline; Isoquinolines; Liver; Liver Diseases; Male; Mice; Orga | 1985 |
Pharmacological manipulation of the chronic granulomatous reactions in the livers of mice infected with schistosomiasis.
Topics: Animals; Granuloma; Indomethacin; Liver Diseases, Parasitic; Mice; Praziquantel; Schistosoma mansoni | 1985 |
[Vaginal involvement in a case of bilharziasis].
Topics: Adult; Female; Granuloma; Humans; Praziquantel; Schistosoma haematobium; Schistosomiasis; Vagina; Va | 1985 |